echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Food Articles > Anti-snake toxin research has received substantial funding

    Anti-snake toxin research has received substantial funding

    • Last Update: 2021-02-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    make snake venom antidotes from large animals such as horses.
    Wellcome Trust, a London-based biomedical research fund, has announced an ambitious plan to improve the treatment of snake bites in poor countries. Tens of thousands of people die each year from snake bites, in part because the injured are treated with only one effective anti-snake toxin for a class of snakes.
    Wellcome Trust announced an 80 million pound project on May 16th to improve existing treatments and develop anti-snake toxins that can be used to treat different snake bites.
    years of neglect, the tragic global threat of snake bites is now getting more attention. Mark Feinberg, president of the International AIDS Vaccine Initiative, said. The organization also supports research on snake bite treatment.
    in many tropical and subtropical regions, snakes are a daily worry. Between 81,000 and 138,000 people die each year from snake bites, according to a World Health Organization report on snake bite strategy released on May 23. Residents in sub-Saharan Africa and rural India are at the highest risk of death due to limited medical conditions.
    , researchers and policymakers have been less concerned about snake bites and have developed few new treatments. Existing anti-snake toxins require injections of small amounts of snake venom into large animals such as horses to produce antibodies. They must also be refrigerated and treated intravenously or infusions under the care of a doctor, making on-site treatment difficult.
    high-quality anti-snake toxins are also expensive to manufacture, usually only for snake species that extract snake venom, and can have dangerous side effects, such as potentially fatal allergic reactions. In sub-Saharan Africa, where snake bites are hotspots, these drugs are undersupply and often ineffective for local snakes even when hospitals have them.
    Phillip Price, who leads the Wellcome Trust's snake bite research, said the Wellcome Trust and DOCTORS Without Borders, as well as local partners, plan to establish a pan-African network to test promising drug candidates through clinical trials.
    genomics, immunology and structural biology are expected to provide more effective treatments than currently available therapies, said Feinberg. Scientists have found that certain molecules of the Cameroonian and Ghanaian snake venom inhibit toxicity. Other treatments that rely on certain human antibody mixtures can nedes with neurotoxins released by the highly toxic Black Mumba snake
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.